Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Additional information

No mutagenicity assay was performed with ZK 5145 (androstonolone), results of one study with a different ester of androstonolone (androstonolone acetate, ZK 5180, CAS 1164-92-7) is reported.

ZK 5180 (androstonolone acetate) did not show a mutagenic potential in a bacterial reverse mutation assay (Ames test in S. typhimurium strains TA98, TA 100, TA 1538, TA 1535 and TA1537) up to the highest tested concentration of 2.5 mg/plate (at which precipitation of test compound and cytotoxicity were observed) in the absence or presence of extrinsic metabolic activation (liver S9 mix from Aroclor 1254 -treated rats). [Schering AG, Report X233, 1997 -07 -18]

A mutagenic potential of ZK 5145 is not expected based on negative results with other steroid hormones in mutagenicity assays.


Short description of key information:
No data with ZK 5145; read across with results of study with androstonolone acetate (ZK 5180, CAS 1164-92-7):

Gene mutation (bacterial reverse mutation assay / Ames test, GLP, non-audited report): negative with and without metablic activation
[Schering AG, Report X233, 1997-07-18]

Endpoint Conclusion: No adverse effect observed (negative)

Justification for classification or non-classification

Not classified according to Directive 67/548/EEC, Regulation 1272/2008/EC (CLP) and German legislation (TRGS-905) for gestagens. No mutagenicity expected.